Cargando…
Novel Anti-Melanoma Compounds Are Efficacious in A375 Cell Line Xenograft Melanoma Model in Nude Mice
Despite the successes of immunotherapy, melanoma remains one of the deadliest cancers, therefore, the need for innovation remains high. We previously reported anti-melanoma compounds that work by downregulating spliceosomal proteins hnRNPH1 and H2. In a separate study, we reported that these compoun...
Autores principales: | Velayutham, Sadeeshkumar, Seerattan, Ryan, Sultan, Maab, Seal, Trisha, Danthurthy, Samaya, Chinnappan, Baskaran, Landi, Jessica, Pearl, Kaitlyn, Singh, Aveta, Smalley, Keiran S. M., Zaias, Julia, Choi, Jun Yong, Minond, Dmitriy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526148/ https://www.ncbi.nlm.nih.gov/pubmed/37759675 http://dx.doi.org/10.3390/biom13091276 |
Ejemplares similares
-
In Vivo Acute Toxicity Studies of Novel Anti-Melanoma Compounds Downregulators of hnRNPH1/H2
por: Velayutham, Sadeeshkumar, et al.
Publicado: (2023) -
Why do women with melanoma do better than men?
por: Smalley, Keiran SM
Publicado: (2018) -
Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice
por: Avram, Stefana, et al.
Publicado: (2017) -
Inhibition of BRAF and BRAF+MEK drives a metastatic switch in melanoma
por: Smalley, Keiran SM, et al.
Publicado: (2015) -
Histone deacetylase inhibitors: a promising partner for MEK inhibitors in uveal melanoma?
por: Faião-Flores, Fernanda, et al.
Publicado: (2019)